MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 120 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q2 2017. The put-call ratio across all filers is 1.29 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $21,390,000 | -64.1% | 17,250,368 | -10.7% | 0.00% | -62.5% |
Q1 2017 | $59,504,000 | -25.0% | 19,319,568 | -0.6% | 0.01% | -27.3% |
Q4 2016 | $79,325,000 | -35.6% | 19,442,391 | +0.3% | 0.01% | -31.2% |
Q3 2016 | $123,102,000 | +19.2% | 19,386,119 | +1.2% | 0.02% | +14.3% |
Q2 2016 | $103,265,000 | -29.1% | 19,158,769 | +10.1% | 0.01% | -30.0% |
Q1 2016 | $145,714,000 | +6.4% | 17,409,085 | +0.4% | 0.02% | +11.1% |
Q4 2015 | $136,956,000 | -3.7% | 17,336,119 | +3.7% | 0.02% | -10.0% |
Q3 2015 | $142,226,000 | -30.3% | 16,712,869 | +1.3% | 0.02% | -23.1% |
Q2 2015 | $204,068,000 | +6.4% | 16,503,650 | +2.3% | 0.03% | +8.3% |
Q1 2015 | $191,737,000 | +6.8% | 16,139,452 | +1.6% | 0.02% | +4.3% |
Q4 2014 | $179,473,000 | +30.3% | 15,882,620 | +1.2% | 0.02% | +21.1% |
Q3 2014 | $137,742,000 | +21.8% | 15,688,138 | +1.1% | 0.02% | +26.7% |
Q2 2014 | $113,074,000 | +44.9% | 15,510,772 | +0.1% | 0.02% | +36.4% |
Q1 2014 | $78,059,000 | -4.8% | 15,487,768 | +0.9% | 0.01% | -8.3% |
Q4 2013 | $81,980,000 | +38.4% | 15,352,128 | -1.5% | 0.01% | +33.3% |
Q3 2013 | $59,255,000 | -44.7% | 15,593,412 | -2.1% | 0.01% | -50.0% |
Q2 2013 | $107,245,000 | – | 15,935,258 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Lagoda Investment Management, L.P. | 775,571 | $2,389,000 | 0.93% |
KEMPNER CAPITAL MANAGEMENT INC. | 148,985 | $459,000 | 0.31% |
Yakira Capital Management, Inc. | 248,420 | $765,000 | 0.27% |
GARRISON BRADFORD & ASSOCIATES INC | 87,700 | $270,000 | 0.24% |
Cannell & Co. | 1,212,478 | $3,734,000 | 0.13% |
LeJeune Puetz Investment Counsel LLC | 3,976 | $180,000 | 0.13% |
ALPINE WOODS CAPITAL INVESTORS, LLC | 726,000 | $2,236,000 | 0.12% |
Virtus ETF Advisers LLC | 198,735 | $612,000 | 0.11% |
STONERIDGE INVESTMENT PARTNERS LLC | 199,227 | $614,000 | 0.08% |
Birchview Capital, LP | 44,000 | $136,000 | 0.08% |